欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/H/0419/001
药品名称PERIOLIMEL N4E
活性成分
    • glucose 0.0 00
剂型Emulsion for infusion
上市许可持有人BAXTER SAS 6 avenue Louis Pasteur 78310 Maurepas
参考成员国 - 产品名称France (FR)
互认成员国 - 产品名称
    • Slovenia (SI)
    • Portugal (PT)
    • Germany (DE)
      Olimel Peri 2,5% E Emulsion zur Infusion
    • Belgium (BE)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Lithuania (LT)
      OLIMEL PERI N4E infuzinė emulsija
    • Latvia (LV)
    • Malta (MT)
    • Romania (RO)
      Periolimel N4E
    • Hungary (HU)
      PERIOLIMEL 4 g/l nitrogén elektrolitokkal emulziós infúzió
    • Finland (FI)
    • Poland (PL)
      Olimel Peri N4E
    • Norway (NO)
    • Estonia (EE)
    • Czechia (CZ)
      PERIOLIMEL N4E
    • Cyprus (CY)
      OLIMEL PERI N4E EMULSION FOR INFUSION
    • Bulgaria (BG)
    • Slovakia (SK)
      OLIMEL PERI N4E
    • Greece (GR)
      OLIMEL
    • Italy (IT)
    • Spain (ES)
    • Austria (AT)
      PeriOLIMEL 2,5 % mit Elektrolyten - Emulsion zur Infusion
    • Ireland (IE)
    • Luxembourg (LU)
    • Netherlands (NL)
    • Denmark (DK)
    • Sweden (SE)
许可日期2009/10/23
最近更新日期2024/07/05
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase